Background: Smoking is the leading cause of both lung cancer and emphysema.
Therefore, some patients with stage I ansi II disease will present with co
ntra-indications to resection including a predicted postoperative FEV1 of l
ess than 0.81 or a VO(2)max of less than 10 ml/kg/min. Recently, lung volum
e reduction surgery (LVRS) has re-emerged in the management of emphysema wi
th excellent results.
Methods and Patients: 2 patients are reported with lung cancer in the left
lower lobe and emphysematous destruction in both upper lobes. They, respect
ively, had a predicted postoperative FEV1 of 0.921 l and 0.685 l. No metast
ases were present. Pre-operatively, a COPD index of 0.9 and 0.7 was calcula
ted. A left lower lobectomy together with volume reduction of the left uppe
r lobe was performed through a standard posterolateral thoracotomy.
Results: Pathological examination showed, respectively, stage IIb and stage
Ib disease. The postoperative course was uneventful and 3 months later a F
EV1 of 1.441 for patient 1 and 1.041 for patient 2 were recorded.
Conclusion: These findings suggest that pulmonary function criteria for pul
monary resection have to be revised when patients can undergo simultaneous
lung cancer resection and LVRS. The pre-operatively calculated COPD index c
an be used to predict which patients may not have a decrease in ventilatory
function.